Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -588 | -588 | 0 | -641 | N/A |
| Depreciation Amortization | 330 | 330 | 0 | 186 | N/A |
| Other Working Capital | -981 | -981 | 0 | N/A | N/A |
| Other Operating Activity | 11 | 11 | 0 | 681 | 0 |
| Operating Cash Flow | $-1,228 | $-1,228 | $0 | $226 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -54 | 0 | -106 | N/A |
| Net Acquisitions | 105 | 105 | 0 | N/A | N/A |
| Other Investing Activity | 946 | 946 | 0 | -408 | 0 |
| Investing Cash Flow | $997 | $997 | $0 | $-514 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 456 | 456 | 0 | 13 | 0 |
| Financing Cash Flow | $456 | $456 | $0 | $13 | $N/A |
| Beginning Cash Position | 336 | 336 | 0 | 877 | N/A |
| End Cash Position | 560 | 560 | 0 | 336 | N/A |
| Net Cash Flow | $224 | $224 | $0 | $-541 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,228 | -1,228 | 0 | 226 | N/A |
| Free Cash Flow | -1,228 | -1,228 | 0 | 226 | 0 |